5/30/24 - vrockstar - VEEV - have put this one on my short list of things i'd like to dip buy, even though i admit i think the risk is probably higher they beat and the stock retraces today's (software factor risk off) move. 31x PE isn't cheap. it's about 1.5x PEG at this rate - which is reasonable. 3.5% fcf yield for sales growing mid teens is reasonable too especially given the niche and moat around life sciences which puts them in a slightly more protected space at this size (~28 bn EV) than up starts or more industry general competitors. i like that. the setup isn't too obvious to me enough so that i'd punt long. if they miss i sense i'd need to reassess and learn the co a bit more. if they beat, i might actually chase it. if they beat but stock drops on tmr's inflation print if rates go higher... that's the golden spot to consider a long position.
so i'm on the sidelines but rooting for the bulls as i'd like to find an oppty to own this. but given i've sized up crm today at 30% less of the valuation on similar EPS growth and nearly 2x the fcf yield, i feel comfortable being a bit more patient here.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.